KALLO INC. Signs Strategic Alliance Agreement with PetroData Management Services Limited

KALLO INC. Signs Strategic Alliance Agreement with PetroData Management Services Limited
Exclusive Agreement enhances Kallo’s sales and delivery capacity in Nigeria
MARKHAM, Ontario, Dec 07, 2011 (BUSINESS WIRE) — To enhance Kallo Inc.’s ability to address a global need for the provision of healthcare services in remote areas, the company has signed a formal agreement with PetroData Management Services Limited.

As part of Kallo’s global growth strategy, this agreement enables Kallo to bring the Mobile Care(TM) clinic to areas in great need of such healthcare services through locally known and reputed distributors. PetroData Management Services Limited will sell Kallo’s mobile clinic Mobile Care(TM) and provide local logistic and professional services for implementation and maintenance of the Mobile Care(TM) clinics.

“PetroData Management Services Limited has a well-earned reputation for excellence in data storage, management and customers service,” said John Cecil, CEO, Kallo Inc. “Moreover, we are confident that the company’s executive team, led by Chairman, Eng. Babajide Soyode, has the necessary regional credibility and reach to successfully represent our products and services in the Nigerian market — one that requires Kallo’s innovation to adequately provide healthcare services to remote communities. We look forward to a long and rewarding business relationship.”

“As per WHO, Nigeria has only 2.97 healthcare workers per 1000 population v/s a global average of 9.3,” said Eng. Babajide Soyode. “Through this relationship with Kallo, I am confident that we have the right mix of regional expertise and biomedical technologies needed, to address this urgent need and improve healthcare delivery in Nigeria’s remote communities, I am proud to be associated with Kallo Inc. — a company that I’ve come to know as one that has the right combination of insight, commitment and innovation required to meet the unique healthcare needs of the people of this great country,” said Eng. Babajide Soyode Chairman, PetroData Management Services Limited.

The above news has been filed as an 8K on November 1, 2011.

SOURCE: Kallo Inc.

 

 

CONTACT:

Mansfield Communications Inc. James Daouphars, 416-599-0024 ext. 222 James@mcipr.com

Copyright Business Wire 2011

-0-

---

Garb Oil & Power Corporation Direct Interview from Germany on Big Biz Show – Yahoo! Finance

SALT LAKE CITY , Dec. 7, 2011 /PRNewswire/ – Garb Oil & Power Corporation (USOTC: GARB.PK – News) announces 25 minutes of air time on the “Big Biz Show” which will be broadcasting live at 1.21 pm KDOW radio or you can listen live online at

http://www.businesstalkradio.net/weekday_host/bbs.shtml

Garb CEO John Rossi will be interviewed on the Big Biz Show by Bob “Sully” Sullivan live on air from Germany while on tour with investors and related parties.

ABOUT GARB:

You can watch our technology in action on the following link http://www.youtube.com/watch?v=dVbZ9SqAYfU

Garb Oil & Power Corporation is dedicated to the application of ClosedCycle(TM) principle and NoWaste(TM) residue. Our plants for Rubber Recycling, E-Waste and E-Scrap Recycling, Waste to Energy and OTR processing are all developed with these principles in mind. Garb believes that processing waste should be economically viable and leave NoWaste(TM). It is our endeavor to build plants that continue to push the boundaries for the attainment of the ClosedCycle (TM) principles and a world with NoWaste(TM).

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. Statements contained in this document that are not historical fact, are forward-looking statements based upon management’s current expectations. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. The results anticipated by any or all of these forward-looking statements may not occur. Garb Oil & Power Corporation is not required to update its forward-looking statements.

Garb Oil & Power Corporation
+1-801-738-1355 Office
John Rossi President & CEO
Email: info@garbmail.com 
Websites: www.garbop.com

 

---

Stock Technical Analysis

 

StockTA.com Stock Technical Analysis Log in

Home

Stock Analysis

Stock Charts

Stock Screen

Watch List

Markets

FOREX

School

Intraday

EMA Analysis

MACD Analysis

RSI Analysis

TDD Analysis

Fibonacci Analysis

High Analysis

Low Analysis

Trend Analysis

Stochastic Analysis

Symbol search

CYTL Analysis

0

CYTL

Intraday Analysis

Add to Watch List

FAQ

Symbol	Last Trade	Date	Change	Open	High	Low	Volume
CYTL	0.135	Dec-02-2011	0.00	0.12	0.135	0.11	55,000

Note: Canadian symbols now end in .c i.e SYMB.C

Analysis	Overall	Short	Intermediate	Long
	Bullish (0.34)	Bullish (0.30)	Bullish (0.44)	Bullish (0.28)

Support/Resistance Type Value Conf. resist. 0.55 20 resist. 0.40 10 resist. 0.30 5 resist. 0.21 5 supp 0.12 34 supp 0.05 16 supp 0.03 2 supp 0.01 2 supp 0.00 17 Chart Indicators Ind. short Inter Long EMA VBu VBu VBu MACD VBu VBu VBu RSI   Bu   TDD   Bu   Fibs Be Bu Be Highs Bu N N Lows Bu Bu N Trends N N N Stoch. Bu     VBu=Very Bullish,    Bu=Bullish N=Neutral Be=Bearish,    VBe=Very Bearish

Printer friendly charts Recent CandleStick Analysis Bullish Date Candle Nov-30-2011 Homing Pigeon Nov-29-2011 Inverted Hammer Nov-28-2011 Homing Pigeon Open Gaps Direction Date range up Oct-14-2011 0.07 to 0.0798 up Aug-30-2011 0.0452 to 0.05 up Mar-10-2011 0.0004 to 0.55 down Oct-26-2011 0.135 to 0.13 down Jun-09-2011 0.248 to 0.15 down Apr-05-2011 0.54 to 0.3

The European Debt Crisis and Your Investments Elliott Wave International (EWI) subscribers were first alerted to the still-developing European debt crisis back in December 2009. Read this FREE report from EWI with commentary and analysis from February 2010 through today, to gain the most unique perspective on the European debt crisis and get ahead of what is yet to come.

America’s Biggest Banks: How Safe Are They? 11/30/2011 4:30:00 PM Source:Elliott Wave International Fifteen major U.S. and European banks were just downgraded by Standard & Poor’s. Please consider this insightful excerpt from a recent Elliott Wave Theorist titled, “The Coming Worldwide Bank run”… Read More

The Financial Ad Trader

Suggestions/Comments/Bugs/Questions? Click here!

 

Market Data Provided by StockWiz

 

©1999-2005 StockTA.com. All Rights Reserved.

 

---

SALT LAKE CITY , Nov. 28, 2011 /PRNewswire/ — Capital Financial Global, Inc. (OTC:CFGX.PK – News), announced today that its insurance lending pipeline has reached $13.9 Million Dollars .

“It’s important that our shareholders know that our core lending business is progressing very well,” said Mr. Paul Norat , CEO of Capital Financial Global, Inc.  ”Taken with our recently acquired distressed gold mine, we have the makings of some nice revenues for the next coming years. As we are able to put more pieces into place, our progress will accelerate more, and more.”

The Company’s insurance lending activities include making loans to insurance trusts, deferred compensation trusts, and other qualified and non-qualified plans, including premium financing on individual policies.

About Capital Financial Global, Inc.

Capital Financial Global, Inc. (OTC:CFGX.PK – News) is a specialty finance company that, unlike traditional banks, helps organizations obtain needed liquidity by using an asset-backed approach rather than a traditional credit approach to originating new loans, buying and selling existing loans, and by converting distressed collateral into cash or trade-able form. The company is publicly traded on the OTC Markets trading system under the symbol “CFGX”.

Our Business Model

The Company makes money by originating new loans, buying and selling existing loans, and by converting distressed collateral into cash or trade-able form.

Market Segments

The market segments the Company operates in are: insurance trusts and pension funds, residential & commercial real estate, precious metals, and investment grade government securities. The Company will also aggressively pursue any other opportunities that fall within its overall strategy.

Forward-looking statements:

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “forecasts,” “potential,” or “continue,” or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.

Contact:
Capital Financial Global, Inc.
www.capfiglobal.com
Email: ir@capfiglobal.com
Tel:  801-747-2000

---

3 Zombie Stocks Poised to Rise From the Dead | Breakout – Yahoo! Finance

---

NXOI Recent News

---

Building the future of interactive media.

Next One Interactive is poised to emerge as a high margin new generation cable medium company, representing the convergence of TV, Mobile devices and the Internet by providing multiple platform dynamics for interactivity on TV and Video On Demand.

 

R & R TV, Inc. is our newest venture which is available in over 26 million households with programs focused on great vacation destinations and real estate. Whether you are home or away R & R has it all.

With the penetration of broadband (high speed internet) in the home, mobile (PDA’s, Phones, iPod) and with the expansion of digital platforms, consumers are now in control of where, when, and how they access content either through text or video.

The term “interactive media” best reflects the critical change that has occurred over the past few years. As a result, traditional one-way (linear) media like television, radio and print (which has historically been broadly distributed to audiences in mass through the one-way broadcast model) is now scrambling as the major shift to both interactive and on-demand media occurs.

While TV has always had the ability to deliver rich media (media that includes sight, sound and motion) to consumers, the platform it delivered media from was not interactive. This presented little challenge in the early days of the web and cellular, as bandwidth issues restricted rich media delivery for both web and mobile devices.

However, the significant advances in bandwidth and the interactive nature of the Internet and mobile devices such as the i-pod, caused significant loss of advertisers as they moved to interactive platforms that were fully trackable.

R & R TV, Inc is one of the first interactive TV networks, offering the consumer the ability to control where, when and how they access content on TV with supporting solutions for web and cellular devices.

Consumers now have over 10,000 entertainment choices. In short, marketing must be done through a non-linear approach that attracts consumers who are the brand ambassadors of today’s media landscape. While still continuing to support linear, non-linear marketing is our area of expertise.

Control is the key driver behind the exploding demand for online video advertising. The interactive market place is undergoing a phenomenal growth curve. Revenues were reported at just over $226 million in 2007, while forecasted advertising spending is being predicted to hit a staggering $45.5 Billion by 2012.

Because of the infinite number of platforms upon which the leading national brand advertisers can allocate spending it is much more difficult for them to plan for and incorporate selected platforms into their advertising mix and resulting media campaigns. Publishers are scrambling to find viable strategies in this new interactive arena that address their need for increasing viewership.

What we offer you

Next One Interactive features high quality Internet websites that attract mass amounts of traffic, creating a brand that our clients can trust.

Our professional team consists of exclusive programmers, creative web designers, dedicated writers, and innovative analysts; all on board to give the public what they desire, and what they need in which ever website of ours that they are inclined to frequent.

 

 

 

Bill Kerby of Next 1 Interactive (NXOI)

 

NXOI Security Details

Transfer Agent(s)

American Stock Transfer & Trust Company

Service Providers

Auditor/Accountant

Legal Counsel

Investor Relations Firm Acorn Management Partners, LC
105 Noble Court
Alpharetta, GA, 30005
United States

 

---

MOORESVILLE, N.C., Oct. 3, 2011 /PRNewswire/ — Sky Power Solutions., (OTCBB:SPOW.ob – News) (www.skypowersolutions.com) an emerging leader in the development and marketing of next generation lithium-powered batteries worldwide, and a leading developer of residential concentrated solar collector electric generating power systems able to produce in excess of 2 Kilowatts (kw) of electric power with ZERO emissions with Sun Light as the only fuel, including built-in heat recapture to provide free hot water to users, will be unveiled and on display during SOLAR POWER INTERNATIONAL 2011 at the Dallas Convention Center in Dallas, Texas October 17 – 20, 2011.  

CLICK HERE TO VIEW SKY POWERS’ VIDEO FOR THE SOLAR COLLECTING SYSTEM:  Sky Power Solutions Video

About Solar Power International (http://www.solarpowerinternational.com) (SPI): is North America‘s largest, most comprehensive solar power trade show and conference. This annual, business-to-business event was the first of its kind in North America and grows bigger and better every year. Nearly 24,000 professionals from 125+ countries attend. With one out of five attendees coming from outside the United States, SPI is truly a global event. In 2011, over 1,100 companies from all vertical markets in the solar power spectrum will exhibit in a space of more than 1 million square feet.  

Sky Power will display a working prototype of the Sky Power Solutions’ Residential, Standalone, Solar Concentrating, Electric Power Generation system in booth number 6056, in the PV Cells and Module area of SPI at the Dallas Convention Center, 650 S. Griffin St., Dallas, Texas 75202.  Company representatives will be available to answer questions during the event. “We are excited to exhibit the Sky Power system at SPI.  Taking about 1/3 the space of standard PV solar panels and the ability to derive heat from the unit makes it very efficient.  In addition to Zero Emissions, users can capture this energy to heat water, further reducing energy consumption from their utility company,” Says Rich Ralston, Public Relations and Media Manager for Sky Power Solutions.

The Sky Power Solutions residential solar power station will have the ability to reduce the average user’s monthly electric grid consumption by up to 30-40% with ZERO emissions and a ZERO carbon footprint; using only solar power.   Visually appealing, the Sky Power Solutions system can easily be installed in most backyards taking less than one third of the space of conventional Solar panels.  The entry level price point for a Sky Power Solutions-Concentrated Solar electric system is estimated to be $5,000 at release.  Multiple units can be combined for increased capacity.

Electric consumption in the United States is increasing at a rate that will outpace the anticipated expansion of the US Electric Grid’s capacity and Sky Power Solutions is poised for expansion into the Residential Electric Power Generation market to allow end users to generate and return 30-40% of their electric usage back to the grid using “Net-Metering” and the Sky Power System.

Sky Power Solutions, the exclusive provider of advanced Lithium Ion battery technology to Li-ion Motors Corp for use in their all electric, zero emission automobiles foresees consumer acceptance of all electric cars will place an increased burden on the US Electric Grid at the same time as additional electric capacity is expected to decline.  Sky Power Solutions is moving to meet this demand, while lowering the grid consumption of users of the Residential Solar Generation System and actually augmenting the Electric Grid by producing and sending electricity from the residential users surplus into the grid, therefore causing the users’ electric meter to run backwards, not only reducing the electric bill, but more importantly adding needed power to a stressed grid for the benefit of all.

FORWARD LOOKING STATEMENT:

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company’s current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ.

CONTACT INFORMATION:

About Sky Power Solutions: www.skypowersolutions.com

For further information: info@skypowersolutions.com

Sky Power Solutions,Corp.
Media Contact: pr@skypowersolutions.com
Investor Relations: ir@skypowersolutions.com
1-888-641-3912

---

SOUTH SAN FRANCISCO, CA–(Marketwire -09/26/11)- VistaGen Therapeutics, Inc. (OTC.BB: VSTA.OB – News), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces the publication of its original research demonstrating the use of pluripotent stem cells to generate insulin in mice.

The research, titled Pdx1 and Ngn3 Overexpression Enhances Pancreatic Differentiation of Mouse ES Cell-Derived Endoderm Population, stems from a collaboration between VistaGen and the laboratories of Dr. Gordon Keller at the University Health Network’s McEwen Centre for Regenerative Medicine in Toronto and Dr. Atsushi Kubo at Nara Medical University in Japan. It was published in the peer-reviewed journal, PLoS ONE 6(9): e24058, doi: 10.1371/journal.pone.0024058 on September 13, 2011.

“In addition to presenting a powerful in vitro model system designed to screen for potential genes or drug candidates capable of inducing the production of insulin-secreting pancreatic beta-islet cells, these research results represent another important step towards our goal of developing superior biological systems for drug development,” said Dr. Ralph Snodgrass, President and Chief Scientific Officer of VistaGen. “We are grateful for the scientific contributions of our international collaborators to the research reported in this publication, as well as the continuing technical progress we are making through our ongoing and active partnership with Dr. Gordon Keller and his laboratory in Toronto.”

VistaGen has an established track record of advancing its internal commercially-focused research and development programs through collaborations that successfully combine the complementary capabilities of its industry leading scientists and those of academic leaders in the field of stem cell research. The published results are the culmination of a close and productive international collaboration initiated and led by VistaGen scientists in the United States.

These studies are part of VistaGen’s versatile Human Clinical Trials in a Test Tube™ platform which has proprietary applications in drug screening, cell therapy, and regenerative medicine in the areas of metabolic disease and diabetes. The stem cell-derived pancreatic cells developed by the international research team demonstrated the ability to produce and correctly process insulin and secrete C-peptide, characteristics of mature beta-islet cells. These studies confirm the utility of regulating two key developmental genetic signals for producing pluripotent stem cell-derived beta-islet cells that produce high levels of insulin. In addition, the specific precursor cell was identified that responds to these signals, suggesting a potential purification or enrichment strategy for beta-islet cell production, facilitating a strategy for the production of large numbers of beta-islet cells for multiple applications. Finally, these studies point to additional areas for future development as well as provide a strong foundation that supports VistaGen’s efforts to produce fully functional human beta-islet cells for drug discovery and clinical applications.

About VistaGen Therapeutics

VistaGen is a biotechnology company applying human pluripotent stem cell technology for drug rescue and cell therapy. Drug rescue involves the combination of human pluripotent stem cell technology with modern medicinal chemistry to generate new chemical variants of once promising small molecule drug candidates that pharmaceutical companies have discontinued during preclinical or early clinical development due to heart or liver toxicity, despite positive efficacy data demonstrating their potential therapeutic and commercial benefits. VistaGen plans to use its pluripotent stem cell technology to generate early indications, or predictions, of how humans will ultimately respond to new drug candidates before they are ever tested in humans.

In parallel with its drug rescue activities and in collaboration with Dr. Gordon Keller in Toronto, VistaGen is preparing to initiate pilot preclinical cell therapy programs involving the proprietary stem cell differentiation and cell production capabilities of its Human Clinical Trials in a Test Tube™ platform.

Additionally, VistaGen will begin a Phase 1b clinical study of AV-101, a small molecule drug candidate for treatment of neuropathic pain, before the end of 2011. This study includes testing AV-101 in healthy volunteers using the intradermal capsaicin model of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S. alone. VistaGen plans to initiate Phase 2 clinical studies of AV-101 in the fourth quarter of 2012. VistaGen is also exploring additional opportunities to leverage its current Phase 1 clinical program to enable additional Phase 2 clinical studies of AV-101 for epilepsy, Parkinson’s disease and depression. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

Visit us at http://www.VistaGen.com, follow us at http://www.twitter.com/VistaGen or view our Facebook page at http://www.facebook.com/VistaGen.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of VistaGen’s ongoing clinical studies, including the safety and efficacy of its drug candidate, AV-101, the failure of future drug rescue and pilot preclinical cell therapy programs related to VistaGen’s stem cell technology-based Human Clinical Trial in a Test Tube™ platform, its ability to enter into drug rescue collaborations, risks and uncertainties relating to the availability of substantial additional capital to support VistaGen’s research, development and commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to AV-101 and any drug rescue variants identified and developed by VistaGen. These and other risks and uncertainties are identified and described in more detail in VistaGen’s filings with the Securities and Exchange Commission (SEC). These filings are available on the SEC’s website at www.sec.gov. VistaGen undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:
H. Ralph Snodgrass, Ph.D.
President and Chief Scientific Officer
VistaGen Therapeutics, Inc.
650-244-9990 x222
Investor.Relations@VistaGen.com
Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com 

---

As we have been seeing when the markets are choppy and moving like a roller coaster, sometimes the best strategy is to just sit back and watch for opportunity,

We have been very careful about navigating in these uncertain times and are sitting on a fair amount of cash watching to take some long positions..

$NFLX as we have heard has taken a Pounding of late but this deal with Dreamworks announced this morning with  will provide some upward shareprice movement.

Dreamworks obviously believes that Netflix will be around and retain their position as King of Streaming…..

---